Genetic investigation of bisphosphonate-related osteonecrosis of jaw (BRONJ) via whole exome sequencing and bioinformatics
- PMID: 25668207
- PMCID: PMC4337898
- DOI: 10.1371/journal.pone.0118084
Genetic investigation of bisphosphonate-related osteonecrosis of jaw (BRONJ) via whole exome sequencing and bioinformatics
Abstract
Complications associated with the use of bisphosphonate (BP) have risen over the years due to an increase in the prescription of BP. BP-related osteonecrosis of jaw (BRONJ), one of the complications linked to the consumption of BP, greatly affects patients with minor dental trauma, incurring a long healing period. While BRONJ afflicts only a minority of patients prescribed with BP, BRONJ is a multigenic disease affected both by environmental and genetic factors having a distinctive phenotype. This study aims to discover genetic biomarkers associated with BRONJ via whole exome sequencing (WES) followed by statistical analysis. Sixteen individuals who had been prescribed with bisphosphonate medication and diagnosed as BRONJ were chosen and each individual's saliva sample was collected for WES. 126 randomized subsamples from the GSK project representing 109 male and 17 female Koreans were used as a control data set. Fisher's exact test was carried out to assess the significance of genetic variants in BRONJ patients. Gene set enrichment analysis (GSEA) (DAVID Bioinformatics Resource 6.7) was used to perform a cluster analysis of variants found from Fisher's exact test. The results from this study suggest that BRONJ-inducing factors are genetically associated and BRONJ occurs due to the malfunctioning of post-translational modification in osteoclast leading to the impairment of cell morphology and adhesion.
Conflict of interest statement
Figures


Similar articles
-
CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.Dentomaxillofac Radiol. 2018 May;47(4):20170323. doi: 10.1259/dmfr.20170323. Epub 2018 Feb 13. Dentomaxillofac Radiol. 2018. PMID: 29365278 Free PMC article.
-
Identifying genetic variants underlying medication-induced osteonecrosis of the jaw in cancer and osteoporosis: a case control study.J Transl Med. 2019 Nov 20;17(1):381. doi: 10.1186/s12967-019-2129-3. J Transl Med. 2019. PMID: 31747953 Free PMC article.
-
Effects of bisphosphonate treatment on DNA methylation in osteonecrosis of the jaw.Mutat Res. 2013 Oct 9;757(2):104-13. doi: 10.1016/j.mrgentox.2013.07.003. Epub 2013 Jul 24. Mutat Res. 2013. PMID: 23892139 Clinical Trial.
-
Current management concepts for bisphosphonate-related osteonecrosis of the jaw: a review.Gen Dent. 2018 Nov-Dec;66(6):e1-e5. Gen Dent. 2018. PMID: 30444713 Review.
-
Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update.Odontostomatol Trop. 2013 Jun;36(142):38-46. Odontostomatol Trop. 2013. PMID: 24073539 Review.
Cited by
-
Prediction of medication-related osteonecrosis of the jaws using machine learning methods from estrogen receptor 1 polymorphisms and clinical information.Front Med (Lausanne). 2023 Jun 21;10:1140620. doi: 10.3389/fmed.2023.1140620. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37415765 Free PMC article.
-
Circulating microRNA Panel as a Novel Biomarker to Diagnose Bisphosphonate-Related Osteonecrosis of the Jaw.Int J Med Sci. 2018 Nov 22;15(14):1694-1701. doi: 10.7150/ijms.27593. eCollection 2018. Int J Med Sci. 2018. PMID: 30588193 Free PMC article.
-
Identification of Potentially Pathogenic Variants Associated with Recurrence in Medication-Related Osteonecrosis of the Jaw (MRONJ) Patients Using Whole-Exome Sequencing.J Clin Med. 2022 Apr 12;11(8):2145. doi: 10.3390/jcm11082145. J Clin Med. 2022. PMID: 35456240 Free PMC article.
-
Bioinformatic Data Mining for Candidate Drugs Affecting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) in Cancer Patients.Dis Markers. 2022 Sep 14;2022:3348480. doi: 10.1155/2022/3348480. eCollection 2022. Dis Markers. 2022. PMID: 36157219 Free PMC article.
-
Genome-wide association study of osteonecrosis of the jaw in Danish patients receiving antiresorptive therapy for osteoporosis: A case-control study.Bone Rep. 2022 Dec 15;18:101648. doi: 10.1016/j.bonr.2022.101648. eCollection 2023 Jun. Bone Rep. 2022. PMID: 36582190 Free PMC article.
References
-
- Carter G, Goss AN, Doecke C (2005) Bisphosphonates and avascular necrosis of the jaw: a possible association. Med J Aust 182: 413–415. - PubMed
-
- Greenberg MS (2004) Intravenous bisphosphonates and osteonecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98: 259–260. - PubMed
-
- Stafford RS, Drieling RL, Hersh AL (2004) National trends in osteoporosis visits and osteoporosis treatment, 1988–2003. Arch Intern Med 164: 1525–1530. - PubMed
-
- Wang J, Goodger NM, Pogrel MA (2003) Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 61: 1104–1107. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources